{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:43:15Z","timestamp":1792773795090,"version":"4.5.0"},"reference-count":49,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112\u20102321\u2010B\u2010003\u2010001"],"award-info":[{"award-number":["NSTC 112\u20102321\u2010B\u2010003\u2010001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["TAR\/2022\/000207"],"award-info":[{"award-number":["TAR\/2022\/000207"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[2026,1,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disorder characterized by the development of fluid\u2010filled cysts in the kidneys. Tolvaptan is the only FDA\u2010approved drug to treat ADPKD, which has significant side effects, prompting the need for safer novel treatments. Given the pathophysiological similarities between ADPKD and malignant tumors, repurposing anti\u2010cancer compounds signifies a promising strategy. In this study, we explored the therapeutic potential of a novel spirocyclic compound 4l with anti\u2010cancer effects in ADPKD. Our preliminary results demonstrated that 4l reduced cell viability in a dose\u2010dependent manner and inhibited cyst growth in 3D culture. Transcriptomic analysis indicated hypoxia\u2010related pathways, mitophagy, and necroptosis (\n                    <jats:italic>Ripk1<\/jats:italic>\n                    and\n                    <jats:italic>Mlkl<\/jats:italic>\n                    activation) as key mechanisms, alongside cell cycle arrest via\n                    <jats:italic>Cdkn1a\u2010Rb1<\/jats:italic>\n                    pathway and inhibition of fibrotic markers (\n                    <jats:italic>Tgfb2<\/jats:italic>\n                    and\n                    <jats:italic>Col4a6<\/jats:italic>\n                    ). To strengthen the translational relevance, we established an ADPKD iPSC\u2010derived renal epithelial model, confirming successful differentiation into proximal tubule\/collecting duct\u2010like cells (LTL\/DBA staining and upregulation of renal markers\n                    <jats:italic>AQP1<\/jats:italic>\n                    ,\n                    <jats:italic>LRP2<\/jats:italic>\n                    , and\n                    <jats:italic>GATA3<\/jats:italic>\n                    ). Differentiated ADPKD cells exhibited hyperproliferation, reflecting the cystic epithelium observed in\u00a0vivo. 4l treatment significantly reduced cell viability without immediate cytotoxicity, suggesting a cytostatic effect. Our findings emphasize 4l as a multi\u2010target agent, proficient in reducing cystogenesis through mitophagy induction, modulation of necroptosis, cell cycle inhibition, and suppression of fibrosis. 4l's efficiency across 2D, 3D, and iPSC\u2010derived models highlights its therapeutic potential. This study also recognizes mitophagy and necroptosis as novel targets in ADPKD and corroborates iPSC\u2010derived renal cells as a powerful platform for drug screening.\n                  <\/jats:p>","DOI":"10.1096\/fj.202503323r","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T15:20:42Z","timestamp":1767194442000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi\u2010Target Effects of Novel Synthetic Indanedione\u2010Based Spirotransdicalinol Compound 4l in Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.1096","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6253-247X","authenticated-orcid":false,"given":"Pallavi","family":"Devapatla","sequence":"first","affiliation":[{"name":"Department of Life Science National Taiwan Normal University  Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3203-047X","authenticated-orcid":false,"given":"Yu\u2010Han","family":"Teng","sequence":"additional","affiliation":[{"name":"Department of Life Science National Taiwan Normal University  Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4512-1511","authenticated-orcid":false,"given":"Poorna Chandrasekhar","family":"Settipalli","sequence":"additional","affiliation":[{"name":"Department of Chemistry, School of Applied Science and Humanities Vignan's Foundation for Science, Technology, and Research  Guntur Andhra Pradesh India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6897-4085","authenticated-orcid":false,"given":"Pavan kumar Reddy","family":"Yeruva","sequence":"additional","affiliation":[{"name":"Department of Chemistry, School of Applied Science and Humanities Vignan's Foundation for Science, Technology, and Research  Guntur Andhra Pradesh India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7435-0714","authenticated-orcid":false,"given":"Hsiu Mei","family":"Hsieh\u2010Li","sequence":"additional","affiliation":[{"name":"Department of Life Science National Taiwan Normal University  Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9383-2882","authenticated-orcid":false,"given":"Anwar","family":"Shaik","sequence":"additional","affiliation":[{"name":"Department of Chemistry, School of Applied Science and Humanities Vignan's Foundation for Science, Technology, and Research  Guntur Andhra Pradesh India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"e_1_2_9_2_1","unstructured":"Y.Pei T.Watnick andB. A.Raby \u201cAutosomal Dominant Polycystic Kidney Disease (ADPKD): Genetics of the Disease and Mechanisms of Cyst Growth \u201dUpToDate; ed. J. P. Forman UpToDate: Waltham MA USA (2020)."},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32782-X"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2025.2492374"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.0310"},{"key":"e_1_2_9_6_1","article-title":"KDIGO 2025 Autosomal Dominant Polycystic Kidney Disease Guidelines: Real\u2010World Perspectives on Nomenclature, Tolvaptan Use, and Polycystic Liver Disease","author":"Reddy B. V.","year":"2025","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells14151203"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00023.x"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0b013e3283621510"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2014.137"},{"key":"e_1_2_9_11_1","volume-title":"StatPearls","author":"Mahboob M.","year":"2024"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S286952"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab312"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI44145"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2012.01.005"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI72272"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3363"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-018-1951-5"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033626"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011040340"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3693625"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2013.256"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47090715"},{"key":"e_1_2_9_25_1","first-page":"52","article-title":"Advances in the Synthesis of Spiro\u2010Compounds, Shandong","volume":"47","author":"Chen Y.","year":"2018","journal-title":"Chemistry & Industry"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules15128827"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2014.06.056"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113263"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s44222-023-00063-3"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01809-0"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12050766"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep12337"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202100915"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1039\/D2RA06076K"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1039\/D2CC03562F"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.050342"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201801358"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030483"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2017.10.026"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2017.09.004"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e16-08-0597"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082197"},{"key":"e_1_2_9_43_1","first-page":"599","volume-title":"Seminars in Nephrology","author":"Theodorakopoulou M.","year":"2019"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00768.x"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom14020207"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42154-0"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00104.2019"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpet.2025.103655"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-13-8871-2_5"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.514166"}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.202503323R","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fj.202503323R","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.202503323R","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:13:06Z","timestamp":1792771986000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fj.202503323R"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,15]]}},"alternative-id":["10.1096\/fj.202503323R"],"URL":"https:\/\/doi.org\/10.1096\/fj.202503323r","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"assertion":[{"value":"2025-09-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e71409"}}